HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ju Bai Selected Research

Anaphase-Promoting Complex-Cyclosome Apc7 Subunit

1/2022Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ju Bai Research Topics

Disease

10Multiple Myeloma
01/2020 - 06/2012
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2010
8Neoplasms (Cancer)
01/2022 - 12/2014
6Leukemia
01/2021 - 01/2013
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2014
3Residual Neoplasm
01/2020 - 01/2013
2Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
01/2021 - 06/2019
2Carcinogenesis
01/2021 - 09/2017
2Hematologic Neoplasms (Hematological Malignancy)
10/2019 - 01/2015
1Respiratory Insufficiency (Respiratory Failure)
10/2019
1Hyperthermia
10/2019
1Lymphoma (Lymphomas)
10/2019
1Shock
10/2019
1Pathologic Complete Response
01/2019
1Leukopenia
12/2018
1Thrombocytopenia (Thrombopenia)
12/2018
1Nasopharyngeal Carcinoma
07/2018
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2018
1Aplastic Anemia (Anemia, Hypoplastic)
12/2017
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2016
1Hypersensitivity (Allergy)
04/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2016
1Drug-Related Side Effects and Adverse Reactions
04/2016
1Infections
01/2015

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
5Proteins (Proteins, Gene)FDA Link
07/2018 - 01/2013
4Peptides (Polypeptides)IBA
01/2021 - 01/2013
3AntigensIBA
01/2021 - 12/2014
3EpitopesIBA
01/2021 - 12/2014
3Long Noncoding RNAIBA
01/2020 - 02/2018
2Circular RNAIBA
01/2022 - 01/2018
2HLA-A*02:01 antigenIBA
01/2021 - 12/2014
2MicroRNAs (MicroRNA)IBA
10/2020 - 09/2017
2Thalidomide (Thalomid)FDA Link
12/2019 - 10/2015
2Chimeric Antigen ReceptorsIBA
10/2019 - 12/2018
2Tumor Biomarkers (Tumor Markers)IBA
06/2012 - 10/2010
1Anaphase-Promoting Complex-Cyclosome Apc7 SubunitIBA
01/2022
1Anaphase-Promoting Complex-CyclosomeIBA
01/2022
1N-methyladenosineIBA
01/2021
1Protein Subunit VaccinesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Proteasome InhibitorsIBA
01/2020
1VER 155008IBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2020
1Semaphorins (Semaphorin)IBA
01/2020
1Small Nucleolar RNA (snoRNA)IBA
01/2020
1Platelet Factor 4IBA
12/2019
1tocilizumab (atlizumab)FDA Link
10/2019
1B-Cell Maturation AntigenIBA
12/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018
1thymoglobulinFDA Link
12/2017
1NucleotidesIBA
09/2017
1CationsIBA
06/2016
1Blood Proteins (Serum Proteins)IBA
06/2016
1Inosine Triphosphate (ITP)IBA
06/2016
1Small Interfering RNA (siRNA)IBA
01/2015
1CateninsIBA
01/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2015
1Transcription Factor 7-Like 2 ProteinIBA
01/2015
1Busulfan (Busulfex)FDA Link
01/2015
1fludarabineIBA
01/2015
1Amino AcidsFDA Link
12/2014
1Fibrinogen (Factor I)FDA Link
01/2013
1Protein Isoforms (Isoforms)IBA
01/2013

Therapy/Procedure

3Immunotherapy
01/2021 - 12/2014
3Therapeutics
12/2018 - 01/2014
3Drug Therapy (Chemotherapy)
11/2018 - 01/2013
1Induction Chemotherapy
11/2018
1Salvage Therapy
11/2018
1Aftercare (After-Treatment)
10/2015
1Hematopoietic Stem Cell Transplantation
01/2015